Riskpilot← Back to searchSign inGet full accessSimedical AB
ABActiveOrg 5590201777Aschebergsgatan 39Activities of performing arts · NACE 9020Est. 20150 employees
Revenue 2024
SEK 128K
-34% vs 2023
EBITDA margin
90.3%
-28% vs 2023
Equity ratio
60.3%
Financial strength
Net profit 2024
SEK 92K
-28% vs 2023
| Revenue | SEK 128K | -34% |
| EBITDA | SEK 116K | -28% |
| Net profit | SEK 92K | -28% |
| Total assets | SEK 307K | +32% |
| Equity | SEK 185K | +4% |
| Employees | 0 | — |
Legal name
Simedical AB
Org number
5590201777
Legal form
Aktiebolag
NACE code
9020 · Activities of performing arts
Founded
8 juli 2015
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall syssla med medicinsk rådgivning, utbildning inom det medicinska området, och därmed förenlig verksamhet
Address
Aschebergsgatan 39
Email
magnus.simren@medicine.gu.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 61 | 154 | 115 | 193 | 128 |
| Staff expenses | — | — | −0 | −3 | −0 |
| EBITDA | 47 | 125 | 107 | 161 | 116 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 47 | 125 | 107 | 161 | 116 |
| Net financials | — | — | 0 | 0 | 0 |
| Profit before tax | 47 | 125 | 107 | 162 | 116 |
| Tax | −10 | −27 | −22 | −34 | −25 |
| Net profit | 37 | 98 | 85 | 128 | 92 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 99 | 215 | 160 | 232 | 307 |
| Equity | 87 | 185 | 135 | 178 | 185 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 12 | 30 | 24 | 54 | 122 |
| Total debt | 12 | 30 | 24 | 54 | 122 |
EBITDA margin
90.3%
This company
15.8%
Market median
+472% vs market
20202024
Equity ratio
60.3%
This company
38.2%
Market median
+58% vs market
20202024
Return on equity
49.6%
This company
18.4%
Market median
+170% vs market
20202024
Net profit margin
71.4%
This company
8.1%
Market median
+781% vs market
20202024
Asset turnover
0.42×
This company
1.12×
Market median
-63% vs market
20202024
Debt / equity
0.66×
This company
0.62×
Market median
+6% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Chairman | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Simedical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eva Yvonne Simrén | Board of Directors | 0 companies |
| Joel Nils Oskar Simrén | Board of Directors | 0 companies |
| Jan Rune Magnus Simrén | Chairman | 0 companies |